Cancer Chemother Pharmacol
Chromatography, High Pressure LiquidHalf-LifeHormones
Dr. Roy M. Ambinder, MD
NPI1770549115
- Medicare services, 2024
- 19,755
- Medicare patients, 2024
- 553
- Part D claims, 2024
- 246
- Publications
- 1
- MIPS score, 2024
- 75
- Practice address
- 601 E Altamonte Dr, Altamonte Springs, FL 32701
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Adventhealth Altamonte Springs - HOPD
Acute Care Hospital outpatient department · Altamonte Springs, Florida
Find Dr. Ambinder's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Roy M. Ambinder is a medical oncologist in Altamonte Springs, Florida
Dr. Ambinder practices at Adventhealth Altamonte Springs - HOPD in Altamonte Springs, Florida.
Dr. Ambinder's NPI, 1770549115, was assigned on April 25, 2006. Dr. Ambinder graduated from Vagelos College of Physicians and Surgeons in 1975. Dr. Ambinder holds Florida license ME35288.
NPI and contact details
- NPI
- 1770549115NPI Registry (opens in a new tab)
- NPI enumeration date
- April 25, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 77
- Medical school graduation
- 1975
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Roy M. Ambinder practices at Adventhealth Altamonte Springs - HOPD in Altamonte Springs, Florida
Dr. Ambinder's primary practice is Adventhealth Altamonte Springs - HOPD, at 601 E Altamonte Dr, Altamonte Springs, FL 32701.
- Adventhealth Altamonte Springs - HOPD601 E Altamonte Dr, Altamonte Springs, FL 32701
Source: Dmand AI Affiliation Data
Dr. Roy M. Ambinder is affiliated with 4 sites of care and 1 medical group
Dr. Ambinder's primary practice is Adventhealth Altamonte Springs - HOPD in Altamonte Springs, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Ambinder to 2 more physician offices and 1 group practice or clinic, each named with a free account.
Adventhealth Altamonte Springs - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Roy M. Ambinder's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ambinder practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Adventhealth Altamonte Springs - HOPD | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Ambinder practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Roy M. Ambinder is one of 477 medical oncologists in Florida
Medical oncology is Dr. Ambinder's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ambinder is board certified in hematology by the American Board of Internal Medicine. Dr. Ambinder is licensed in Florida.
Specialties and state licenses
- Medical oncology, FloridaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Ambinder treats.
Medical oncologists near Dr. Ambinder
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
477medical oncologists in Florida
4medical oncologists in Altamonte Springs
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Roy M. Ambinder billed Medicare for 19,755 services in 2024
CMS data shows 19,755 Medicare services from Dr. Ambinder across 16 procedure codes in 2024, for 553 Medicare patients. Medicare paid $183,143 for them. Every service was in an office.
Medicare services, 202419,755
Medicare patients553
Paid by Medicare$183,143
Procedure codes16
Dr. Ambinder's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 43,8602024: 9,69078%
- Drugs given in the office
- 2023: 92,3872024: 7,35392%
- Lab and pathology
- 2023: 3,4342024: 1,01570%
- Surgery
- 2023: 3,1132024: 81674%
- Tests and treatments
- 2023: 4,2792024: 81381%
- Office and hospital visits
- 2023: 2,2722024: 6897%
Dr. Ambinder compared with the Florida median for medical oncologists, 2024
- Dr. Ambinder
- Florida median
- Medicare services
- 19,755vs 19,755Close to median
- Medicare patients
- 553vs 541Close to median
- Part D claims
- 122vs 59880% below
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Ambinder's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ambinder?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ambinder and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Roy M. Ambinder treated 553 Medicare patients in 2024, average age 76
CMS counts 553 Medicare patients who saw Dr. Ambinder in 2024. The largest group is 75 to 84, with 246 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Ambinder's median patient age at 68, with 58% women.
Medicare patients, 2024553
Average age76
Average risk score2.21
Also on Medicaid12%
Dr. Ambinder's Medicare patients by age, 2024
Dr. Ambinder's Medicare patients by sex, 2024
- Women33160%
- Men22240%
Chronic conditions among Dr. Ambinder's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis54%
- Ischemic heart disease47%
- Chronic kidney disease46%
- Diabetes40%
- Cancer35%
- COPD28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Ambinder's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women58%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Roy M. Ambinder wrote 246 Medicare Part D claims in 2024
In 2024, Dr. Ambinder wrote 246 Medicare Part D claims for 92 patients. 58% of them were for generic drugs. CMS names the drug for 122 of them, across 7 drugs with 11 or more claims each, at $404,421 in total drug cost. In 2023, CMS named 791 claims across 29 drugs.
Part D claims, 2024246
Drugs named by CMS7
Total drug cost$404,421
Part D patients92
Dr. Ambinder's Part D claims by kind of drug, 2024
- Generic142 claims58%
- Brand-name104 claims42%
Dr. Ambinder's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7912024: 12285%
Drugs named by CMS: 7 in 2024, 29 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Roy M. Ambinder scored 75 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ambinder for performance year 2024, reported as part of a group.
- MIPS final score, 2024
- 75 of 100
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Ambinder by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Roy M. Ambinder has 1 publication on record
Dmand AI links 1 paper to Dr. Ambinder.
Papers1
Recent publications by Dr. Ambinder
See who Dr. Ambinder researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ambinder works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Roy M. Ambinder received $1,218 in industry payments from 2016 to 2025
CMS Open Payments shows 62 general payments to Dr. Ambinder from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $213.
General payments to Dr. Ambinder by program year, 2016 to 2025
Companies that paid Dr. Ambinder the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Roy M. Ambinder has 1 award and honors on record
Dmand AI lists 1 award for Dr. Ambinder, most recently CMS Stage 1 EHR in 2014.
Awards and honors for Dr. Ambinder
- 2014
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Roy M. Ambinder graduated from Vagelos College of Physicians and Surgeons
Dr. Ambinder graduated from Vagelos College of Physicians and Surgeons in 1975. Dr. Ambinder is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Roy M. Ambinder accepts plans from 5 insurance carriers
Dr. Ambinder is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Cigna
- Molina
- CMS Medicare
Plan types Dr. Ambinder accepts, by number of carriers
- Medicare5
- HMO4
- PPO3
- EPO2
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Roy M. Ambinder's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Roy M. Ambinder
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Roy M. Ambinder's NPI number?
Dr. Roy M. Ambinder's NPI number is 1770549115. It was assigned on April 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Roy M. Ambinder?
Dr. Roy M. Ambinder is a medical oncologist in Altamonte Springs, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Roy M. Ambinder practice?
Dr. Ambinder practices at 601 E Altamonte Dr, Altamonte Springs, FL 32701. Dr. Ambinder's primary practice is Adventhealth Altamonte Springs - HOPD in Altamonte Springs, Florida. Dmand AI also links Dr. Ambinder to 2 physician offices and 1 group practice or clinic.
What is Dr. Roy M. Ambinder's medical license number?
Dr. Ambinder holds Florida license ME35288.
What medical group is Dr. Roy M. Ambinder part of?
Dr. Ambinder is linked to Florida Cancer Specialists & Research Institute.
Does Dr. Roy M. Ambinder accept Medicare?
Yes. CMS data shows Dr. Ambinder billed Medicare for 19,755 services in 2024.
What is Dr. Roy M. Ambinder's MIPS score?
Dr. Ambinder's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.
How many Medicare patients does Dr. Roy M. Ambinder see?
CMS counts 553 Medicare patients who saw Dr. Ambinder in 2024, with an average age of 76.
Is Dr. Roy M. Ambinder board certified?
Yes. Dr. Ambinder is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Roy M. Ambinder bill to Medicare?
In 2024, Dr. Ambinder's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J1569) and injected or infused drug (J0885).
Show 6 more questionsShow fewer questions
Where did Dr. Roy M. Ambinder go to medical school?
Dr. Ambinder graduated from Vagelos College of Physicians and Surgeons in 1975.
What drugs does Dr. Roy M. Ambinder prescribe most?
In 2024 Medicare Part D data, Dr. Ambinder's most prescribed drugs by claims were Anastrozole, Allopurinol and Eliquis.
Has Dr. Roy M. Ambinder received payments from drug or device companies?
CMS Open Payments shows $1,218 in general payments to Dr. Ambinder from 23 companies from 2016 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Roy M. Ambinder been practicing?
Dr. Ambinder graduated from medical school in 1975, 51 years ago.
Does Dr. Roy M. Ambinder do research?
Dmand AI links 1 publication to Dr. Ambinder.
What insurance does Dr. Roy M. Ambinder accept?
Dr. Ambinder is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card